Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia

References

• Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.
   PubMed Web of Science ®Google Scholar
• Teachey DT, Pui CH. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol. 2019;20(3):e142–e154.
   PubMed Web of Science ®Google Scholar
• Bhojwani D, Pui CH. Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol. 2013;14(6):e205–e217.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Moretta F, Rutella S. Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches. Curr Opin Oncol. 2013;25(6):707–715.
   PubMed Web of Science ®Google Scholar
• Tissing WJ, Meijerink JP, den Boer ML, et al. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia. 2003;17(1):17–25.
   PubMed Web of Science ®Google Scholar
• Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 2010;11(11):1096–1106.
   PubMed Web of Science ®Google Scholar
• Delgado-Martin C, Meyer LK, Huang BJ, et al. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias. Leukemia. 2017;31(12):2568–2576.
   PubMed Web of Science ®Google Scholar
• Klumper E, Pieters R, Veerman AJ, et al. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood. 1995;86(10):3861–3868.
   PubMed Web of Science ®Google Scholar
• Icard P, Shulman S, Farhat D, et al. How the Warburg effect supports aggressiveness and drug resistance of cancer cells. Drug Resist Updat. 2018;38:1–11.
   PubMed Web of Science ®Google Scholar
• Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.
   PubMed Web of Science ®Google Scholar
• Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11(6):393–410.
   PubMed Web of Science ®Google Scholar
• Spencer JA, Ferraro F, Roussakis E, et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature. 2014;508(7495):269–273.
   PubMed Web of Science ®Google Scholar
• Sbarba P D, Cheloni G. Tissue “hypoxia” and the maintenance of leukemia stem cells. Adv Exp Med Biol. 2019; 1143:129–145.
   PubMed Web of Science ®Google Scholar
• Dumas PY, Naudin C, Martin-Lannerée S, et al. Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5- and hypoxia- dependent up-regulation of AXL. Haematologica. 2019;104(10):2017–2027.
   PubMed Web of Science ®Google Scholar
• Wielockx B, Grinenko T, Mirtschink P, et al. Hypoxia pathway proteins in normal and malignant hematopoiesis. Cells. 2019;8(2):155.
   Web of Science ®Google Scholar
• Chen Y, Liang Y, Luo X, et al. Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy. Cell Death Dis. 2020;11(4):291.
   PubMed Web of Science ®Google Scholar
• Huang X, Trinh T, Aljoufi A, et al. Hypoxia signaling pathway in stem cell regulation: good and evil. Curr Stem Cell Rep. 2018;4(2):149–157.
   PubMed Web of Science ®Google Scholar
• Gu L, Zhang G, Zhang Y. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines. J Exp Clin Cancer Res. 2019;38(1):269.
   PubMedGoogle Scholar
• Coley HM. Development of drug-resistant models. Methods Mol Med. 2004;88:267–273.
   PubMedGoogle Scholar
• Watson MB, Lind MJ, Cawkwell L. Establishment of in-vitro models of chemotherapy resistance. Anticancer Drugs. 2007;18(7):749–754.
   PubMed Web of Science ®Google Scholar
• Bhandari V, Hoey C, Liu LY, et al. Molecular landmarks of tumor hypoxia across cancer types. Nat Genet. 2019;51(2):308–318.
   PubMed Web of Science ®Google Scholar
• Yang L, Shi P, Zhao G, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5(1):8.
   PubMed Web of Science ®Google Scholar
• Zawydiwski R, Harmon JM, Thompson EB. Glucocorticoid-resistant human acute lymphoblastic leukemic cell line with functional receptor. Cancer Res. 1983;43(8):3865–3873.
   PubMed Web of Science ®Google Scholar
• Foley GE, Lazarus H, Farber S, et al. Continuous culture of human lymphoblasts from peripheral blood of a child with acute luekemia. Cancer. 1965;18: 522–529.
   PubMed Web of Science ®Google Scholar
• Gu L, Yi Z, Zhang Y, et al. Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia. Oncotarget. 2017;8(19):30978–30991.
   PubMedGoogle Scholar
• Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21(5):268–283.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Carling D. The AMP-activated protein kinase–fuel gauge of the mammalian cell. Eur J Biochem. 1997;246(2):259–273.
   PubMedGoogle Scholar
• Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251–262.
   PubMed Web of Science ®Google Scholar
• Chipurupalli S, Kannan E, Tergaonkar V, et al. Hypoxia induced ER stress response as an adaptive mechanism in cancer. Int J Mol Sci. 2019;20(3):749.
   Web of Science ®Google Scholar
• Hu YL, Jahangiri A, De Lay M, et al. Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy. Autophagy. 2012;8(6):979–981.
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437.
   PubMed Web of Science ®Google Scholar
• Carnero A, Lleonart M. The hypoxic microenvironment: A determinant of cancer stem cell evolution. Bioessays. 2016;38: Suppl S65–S74.
   PubMed Web of Science ®Google Scholar
• Konopleva M, Tabe Y, Zeng Z, et al. Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches. Drug Resist Updat. 2009;12(4-5):103–113.
   PubMed Web of Science ®Google Scholar
• Rieger CT, Fiegl M. Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia. Exp Hematol. 2016;44(7):578–582.
   PubMed Web of Science ®Google Scholar
• Benito J, Shi Y, Szymanska B, et al. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. PLoS One. 2011;6(8):e23108.
   PubMed Web of Science ®Google Scholar
• Wood C, Harutyunyan K, Sampaio D, et al. Photoacoustic-based oxygen saturation assessment of murine femoral bone marrow in a preclinical model of leukemia. Photoacoustics. 2019;14:31–36.
   PubMed Web of Science ®Google Scholar
• Konopleva M, Thall PF, Yi CA, et al. Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia. Haematologica. 2015;100(7):927–934.
   PubMed Web of Science ®Google Scholar
• Adesida AB, Mulet-Sierra A, Jomha NM. Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells. Stem Cell Res Ther. 2012;3(2):9.
   PubMed Web of Science ®Google Scholar
• Basciano L, Nemos C, Foliguet B, et al. Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status. BMC Cell Biol. 2011;12:12.
   PubMed Web of Science ®Google Scholar
• Santos F D, Andrade PZ, Boura JS, et al. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol. 2010;223(1):27–35.
   PubMed Web of Science ®Google Scholar
• Kumar S, Vaidya M. Hypoxia inhibits mesenchymal stem cell proliferation through HIF1α-dependent regulation of P27. Mol Cell Biochem. 2016;415(1-2):29–38.
   PubMed Web of Science ®Google Scholar
• Pezzi A, Amorin B, Laureano Á, et al. Effects of hypoxia in long-term In vitro expansion of human bone marrow derived mesenchymal stem cells. J Cell Biochem. 2017;118(10):3072–3079.
   PubMed Web of Science ®Google Scholar
• Drolle H, Wagner M, Vasold J, et al. Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy. Leuk Res. 2015;39(7):779–785.
   PubMed Web of Science ®Google Scholar
• Itoh M, Okuhashi Y, Takahashi Y, et al. Hypoxia Up-regulates HIF expression while suppressing cell growth and NOTCH activity in leukaemia cells. Anticancer Res. 2019;39(8):4165–4170.
   PubMedGoogle Scholar
• Ng KP, Manjeri A, Lee KL, et al. Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition. Blood. 2014;123(21):3316–3326.
   PubMed Web of Science ®Google Scholar
• Koczula KM, Ludwig C, Hayden R, et al. Metabolic plasticity in CLL: adaptation to the hypoxic niche. Leukemia. 2016;30(1):65–73.
   PubMed Web of Science ®Google Scholar
• Lodi A, Tiziani S, Khanim FL, et al. Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulation. ACS Chem Biol. 2011;6(2):169–175.
   PubMed Web of Science ®Google Scholar
• Hui S, Ghergurovich JM, Morscher RJ, et al. Glucose feeds the TCA cycle via circulating lactate. Nature. 2017;551(7678):115–118.
   PubMed Web of Science ®Google Scholar
• Lee Y, Jung J, Cho KJ, et al. Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem. 2013;114(1):79–88.
   PubMed Web of Science ®Google Scholar
• Liu J, Hao H, Huang H, et al. Hypoxia regulates the therapeutic potential of mesenchymal stem cells through enhanced autophagy. Int J Low Extrem Wounds. 2015;14(1):63–72.
   PubMed Web of Science ®Google Scholar
• Degwert N, Latuske E, Vohwinkel G, et al. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia. Eur J Haematol. 2016;97(3):239–244.
   PubMed Web of Science ®Google Scholar
• Petit C, Gouel F, Dubus I, et al. Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways. BMC Cancer. 2016;16(1):746.
   PubMedGoogle Scholar